Hillhurst Biopharmaceuticals, Inc.

Liberating patients from the burden of sickle cell disease

MONTROSE, United States · Founded 2015 · $2.0M raised

Employees
1–10
Founded
2015
Business Model
B2B
Total Funding
$2.0M
Last Round
GrantMay 2025
Rounds
4

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 4 funding rounds and 2 investors for this company. The full record is or through the API.

About

Hillhurst Biopharmaceuticals is a clinical-stage biopharmaceutical company developing novel oral therapies for sickle cell disease and related conditions. Its proprietary GLASS platform enables oral delivery of therapeutic agents that are safer and more convenient for at-home administration. The company's lead candidate HBI-002 targets sickle cell disease and Parkinson's disease, with a follow-on non-opioid compound targeting acute pain.

Summary

Hillhurst Biopharmaceuticals, Inc. is a Biotech company based in MONTROSE, United States, founded in 2015. It has raised $2.0M in total across 4 rounds, most recently a Grant round in May 2025. Investors include National Institutes of Health and Michael J. Fox Foundation.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

GrantMay 2025

Sign up to see all 4 events

Funding: Grant. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Hillhurst Biopharmaceuticals, Inc. on Indexed.vc
<a href="https://indexed.vc/companies/hillhurst-biopharmaceuticals-inc"><img src="https://indexed.vc/api/badge/company/hillhurst-biopharmaceuticals-inc" alt="Hillhurst Biopharmaceuticals, Inc. on Indexed.vc" width="260" height="76" /></a>